Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas.
about
Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas?The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphomaImmune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies.Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma.PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications.Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinomaMechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies.B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.Immunodeficiency and Dysregulation: Report of the 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology.PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based Strategies.Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients.Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status.Cancer Immunotherapy in Diffuse Large B-Cell LymphomaNew developments in immunotherapy for lymphomaThe prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis
P2860
Q28076071-ADC29BBE-D400-433D-B092-F5E701E2A25CQ33597192-3120048E-E988-422E-83D7-F1C0B5B46C3FQ33638083-4D680827-9D5E-4C43-A8EB-ED9EE7D9E25DQ33802505-E75F362B-DA3E-4FBA-8768-26BE46DA158EQ37644975-82300F09-1719-4379-BEF7-AF420BDB2C8BQ37688436-D12DECE8-5822-432B-B61D-AF746D3283C7Q39237785-E37ACF8A-8260-4830-B663-5EE8D761B5E3Q40250056-D2FC28A6-164F-4F60-B338-4E66BCCF179EQ45325729-85BE5528-2DA2-4D44-BD99-50D2D49D1876Q46528091-B16B32E1-711F-44ED-A577-3382C0867CC6Q47424027-0CA86BDC-BBE6-44AB-B4BD-84F3DFF13E93Q51804722-D85B57FF-8C79-4429-8808-D4A8EC0F2105Q52808766-D9C5D3EE-829A-4CD0-84CE-859AC810A9FBQ55307728-B477F34E-E58A-4A84-8399-39B6610009B5Q56889030-79ADB482-B687-445F-BE7A-947B19746680Q58804962-0A2D4592-56BA-4AEB-A44C-99973071D150Q58804963-AE2D7275-6E96-4894-81D7-B263D11354CC
P2860
Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinicopathological analysis o ...... iffuse large B cell lymphomas.
@en
type
label
Clinicopathological analysis o ...... iffuse large B cell lymphomas.
@en
prefLabel
Clinicopathological analysis o ...... iffuse large B cell lymphomas.
@en
P2093
P2860
P356
P1433
P1476
Clinicopathological analysis o ...... iffuse large B cell lymphomas.
@en
P2093
Chul Woo Kim
Dae Seog Heo
Dohee Kwon
Heounjeong Go
Jin Ho Paik
Pil-Jong Kim
Soo Jeong Nam
Tae Min Kim
Yoon Kyung Jeon
P2860
P304
P356
10.1111/HIS.12882
P577
2015-10-01T00:00:00Z